Alport Syndrome: A Comprehensive Review on Genetics, Pathophysiology, Histology, Clinical and Therapeutic Perspectives

阿尔波特综合征 医学 疾病 病理生理学 遗传性疾病 病理 生物信息学 内科学 肾小球肾炎 生物
作者
Ana Luísa Pedrosa,Letícia Bitencourt,Rafaela Moreira Paranhos,Cristiana Afonso Leitáo,Guilherme Costa Ferreira,Ana Cristina Simões e Silva
出处
期刊:Current Medicinal Chemistry [Bentham Science]
卷期号:28 (27): 5602-5624 被引量:35
标识
DOI:10.2174/0929867328666210108113500
摘要

Background: Alport syndrome (AS) is a disease caused by mutations in COL4A3, COL4A4 or COL4A5, the genes that encode distinct chains of type IV collagen. The vast majority of cases present as an inherited disorder, although de novo mutations are present in around 10% of the cases. Methods: This non-systematic review summarizes recent evidence on AS. We discuss the genetic and pathophysiology of AS, clinical manifestations, histopathology, diagnostic protocols, conventional treatment and prognostic markers of the disease. In addition, we summarize experimental findings with novel therapeutic perspectives for AS. Results: The deficient synthesis of collagen heterotrimers throughout the organism leads to impaired basement membranes (BM) in several organs. As a result, the disease manifests in a wide range of conditions, particularly renal, ocular and auricular alterations. Moreover, leiomyomatosis and vascular abnormalities may also be present as atypical presentations. In this framework, diagnosis can be performed based on clinical evaluation, skin or renal biopsy and genetic screening, the latter being the gold standard. There are no formally approved treatments for AS, even though therapeutic options have been described to delay disease progression and increase life expectancy. Novel therapeutic targets under pre-clinical investigation included paricalcitol, sodium-glucose co-transporter- 2 inhibitors, bardoxolone methyl, anti-microRNA-21 oligonucleotides, recombinant human pentraxin-2, lysyl oxidase-like-2 blockers, hydroxypropyl-b-cyclodextrin, sodium 4-phenylbutyrate and stem cell therapy. Conclusion: AS is still a greatly under and misdiagnosed disorder. The pathophysiology is still not fully unnderstand and genetics of the disease have also some gaps. Up to know, there is no specific and effective treatment for AS. Further studies are necessary to establish novel and effective therapeutic protocols.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
吟賞烟霞完成签到,获得积分10
刚刚
1秒前
1秒前
1秒前
顾矜应助科研通管家采纳,获得10
1秒前
1秒前
Orange应助科研通管家采纳,获得10
1秒前
科目三应助科研通管家采纳,获得10
1秒前
思源应助科研通管家采纳,获得10
1秒前
丘比特应助科研通管家采纳,获得30
1秒前
香蕉觅云应助科研通管家采纳,获得10
1秒前
1秒前
1秒前
爆米花应助科研通管家采纳,获得10
2秒前
搜集达人应助科研通管家采纳,获得10
2秒前
斯文败类应助科研通管家采纳,获得10
2秒前
脑洞疼应助科研通管家采纳,获得10
2秒前
wanci应助科研通管家采纳,获得10
2秒前
2秒前
Owen应助科研通管家采纳,获得10
2秒前
隐形曼青应助科研通管家采纳,获得10
2秒前
Lll发布了新的文献求助10
3秒前
开心的半仙完成签到,获得积分10
3秒前
暖橘发布了新的文献求助10
3秒前
4秒前
4秒前
yyymmma应助YAN采纳,获得10
4秒前
CodeCraft应助AAAA采纳,获得10
5秒前
5秒前
诚心八宝粥完成签到,获得积分10
5秒前
hijy关注了科研通微信公众号
6秒前
6秒前
6秒前
6秒前
听话的青荷完成签到,获得积分10
6秒前
淡淡的完成签到,获得积分20
7秒前
7秒前
8秒前
8秒前
陈辉发布了新的文献求助10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 3000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 1100
Signals, Systems, and Signal Processing 510
Discrete-Time Signals and Systems 510
Proceedings of the Fourth International Congress of Nematology, 8-13 June 2002, Tenerife, Spain 500
Le genre Cuphophyllus (Donk) st. nov 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5939751
求助须知:如何正确求助?哪些是违规求助? 7050981
关于积分的说明 15879973
捐赠科研通 5069852
什么是DOI,文献DOI怎么找? 2726896
邀请新用户注册赠送积分活动 1685449
关于科研通互助平台的介绍 1612747